# To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

> **NCT00302549** · NA · COMPLETED · sponsor: **Nanjing University School of Medicine** · enrollment: 61 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** FK506

## Key facts

- **NCT ID:** NCT00302549
- **Lead sponsor:** Nanjing University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-05
- **Final completion:** 2006-02
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2010-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302549, "To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00302549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*